FDA Approves Nexavar for Advanced Thyroid Cancer
Thankfully, m ost thyroid cancers are treatable. However, when thyroid cancer comes back after treatment or spreads to other areas of the body, the disease is harder to treat.
Two New Weapons Against Thyroid Cancer
There hasn’t been much progress in the treatment of advanced thyroid cancer over the last 40 years. And there are really no treatment options for thyroid cancer involving the mutated gene called BRAF. Two new weapons offer good news on both fronts.
Nexavar Gets FDA Nod for Thyroid Cancer
Most thyroid cancers are treatable, even curable. However, as with most cancers, once spreading (metastasis) begins, tumors are more difficult to treat. A medication is being evaluated to strengthen the arsenal against advanced thyroid cancer.
New Rx for Thyroid Cancer
Thyroid cancers are typically (and thankfully) less aggressive than most other cancers but sometimes they cannot be treated using traditional therapy.
Kidney Cancer Patients May Soon Have New Rx
The results of a phase III clinical trial have demonstrated that an investigational drug helped advanced kidney cancer patients live as long as those on the current standard therapy.
Never Too Late for Therapy
Older lung cancer patients who have not responded to standard chemotherapy may be reluctant to continue treatment. Later-stage drug treatment, however, can be effective. Older patients often go under-treated because of concerns that they will not be able to tolerate certain toxic therapies.
Drug Fails to Prolong Cancer Patient Lives
A drug often used to treat kidney and liver cancer may also fight a type of lung cancer. New research, though, shows that it does not extend the lives of lung cancer patients.
Kidney Cancer Drug Updates
At an international oncology meeting, new data has been presented on drugs that treat kidney cancer. The results have been released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Tivozanib for Advanced Kidney Cancer
Right now, there are only a handful of drugs that are approved to treat advanced renal cell carcinoma – a type of kidney cancer. Phase 3 clinical trial results of another drug suggest kidney cancer patients may soon have a new option.
Kidney Cancer Rx Approved in Europe
Kidney cancer doesn’t usually have any warning signs until it has become pretty serious. In fact, about a third of patients are diagnosed with an advanced stage of the disease. A medication has been approved in Europe to treat kidney cancer that has spread.